NeuroAge was founded from a deep personal connection to fighting brain aging. Dr. Christin Glorioso's grandmother passed away from Alzheimer’s disease when she was a child. She witnessed the suffering that brought to her grandmother and to her loved ones. Since that time, she has had a lifelong commitment to creating better therapies to prevent and treat Alzheimer’s. Previously, Dr. Glorioso was a Scientist at MIT, Head of AI of TeachAids, and Chief Strategist of the Bakar Aging Research Institute at UCSF. She completed her MD and PhD in Neuroscience from the University of Pittsburgh and Carnegie Mellon Medical Scientist Training Program and her postdoctoral training at MIT.